General Information
Drug ID
DR00580
Drug Name
Valspodar
Synonyms
3'-Keto-bmt(1)-val(2)-cyclosporin A; Amdray; Amdray (TN); PSC-833; PSC833; Psc 833; SDZ-PSC 833; Sdz psc 833; Sdz-psc-833; Valspodar (USAN/INN)
Drug Type
Small molecular drug
Indication Acute myeloid leukemia [ICD11: 2A60] Discontinued in Phase 3 [1]
Structure
3D MOL 2D MOL
Formula
C63H111N11O12
Canonical SMILES
CC=CCC(C)C(=O)C1C(=O)NC(C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C(C)C
InChI
InChI=1S/C63H111N11O12/c1-26-27-28-41(16)53(76)52-57(80)67-49(38(10)11)61(84)68(19)33-48(75)69(20)44(29-34(2)3)56(79)66-50(39(12)13)62(85)70(21)45(30-35(4)5)55(78)64-42(17)54(77)65-43(18)58(81)71(22)46(31-36(6)7)59(82)72(23)47(32-37(8)9)60(83)73(24)51(40(14)15)63(86)74(52)25/h26-27,34-47,49-52H,28-33H2,1-25H3,(H,64,78)(H,65,77)(H,66,79)(H,67,80)/b27-26+/t41-,42+,43-,44+,45+,46+,47+,49+,50+,51+,52+/m1/s1
InChIKey
YJDYDFNKCBANTM-QCWCSKBGSA-N
CAS Number
CAS 121584-18-7
Pharmaceutical Properties Molecular Weight 1214.6 Topological Polar Surface Area 276
Heavy Atom Count 86 Rotatable Bond Count 15
Hydrogen Bond Donor Count 4 Hydrogen Bond Acceptor Count 12
XLogP
7.7
PubChem CID
5281884
PubChem SID
103756868 , 113856125 , 12014683 , 123120912 , 126682516 , 13393 , 134338954 , 134340628 , 135029355 , 136340329 , 137262651 , 14792638 , 14939450 , 160870061 , 162201859 , 163621062 , 163686385 , 164766082 , 184547718 , 223440908 , 223656435 , 226407940 , 241376778 , 251970981 , 252110095 , 252157735 , 252216124 , 252347722 , 39315469 , 47207934 , 53787223 , 57358436 , 629786 , 80185225 , 8616835
ChEBI ID
CHEBI:8985
TTD Drug ID
D09TGX
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001281)
2 Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.